Manel Essaidi-Laziosi

University of Geneva — Switzerland

Medicine · Health Sciences

13h-index832citations32works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 detection and testing(14), SARS-CoV-2 and COVID-19 Research(13), Respiratory viral infections research(12), COVID-19 Clinical Research Studies(5), Viral gastroenteritis research and epidemiology(5)

Publications32 total

SARS-CoV-2 Delta and Omicron Variants alter Trophoblast Cell Fusion and Syncytiotrophoblast Dynamics: New Insights into Placental Vulnerability
Placenta·2025
SARS-CoV-2 delta and omicron variants alter trophoblast cell fusion and syncytiotrophoblast dynamics: new insights into placental vulnerability
Cell Death and Disease·2025· 1 citedOpen Access
SARS-CoV-2 Delta and Omicron Variants alter Trophoblast Cell Fusion and Syncytiotrophoblast Dynamics: New Insights into Placental Vulnerability
2025Open Access
Age- and Virus-Specific Signatures of <i>In Vitro</i> Reconstituted Human Airway Epithelia in the Presence and Absence of Respiratory Viral Infections
2025Open Access
Immune escape and replicative capacity of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1
2024· 7 citedOpen Access
Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
Virus Research·2023· 2 citedOpen Access
Altered cell function and increased replication of rhinoviruses and EV-D68 in airway epithelia of asthma patients
Frontiers in Microbiology·2023· 11 citedOpen Access
Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
2022Open Access
Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
Microbiology Spectrum·2022· 73 citedOpen Access
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
Nature Communications·2022· 94 citedOpen Access
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
2021· 13 citedOpen Access
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
Nature·2021· 109 citedOpen Access
Sensitivity of SARS-CoV-2 antigen-detecting rapid tests for Omicron variant
2021· 48 citedOpen Access
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
Emerging Microbes & Infections·2021· 59 citedOpen Access
Analytical performance of eleven SARS-CoV-2 antigen-detecting rapid tests for Delta variant
2021· 9 citedOpen Access
Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells
The Lancet Microbe·2021· 30 citedOpen Access
SARS-CoV-2 rapid diagnostic tests for emerging variants
The Lancet Microbe·2021· 42 citedOpen Access
Enhanced fitness of SARS-CoV-2 variant of concern B.1.1.7, but not B.1.351, in animal models
2021· 11 citedOpen Access
Analytical comparison of nine SARS-CoV-2 antigen-detecting rapid diagnostic tests for emerging SARS-CoV-2 variants
2021· 5 citedOpen Access
Assessment of the infectious threshold of SARS-CoV-2 in primary airway epithelial cells
2021Open Access
page 1 of 2Next →

Frequent Co-authors

Laurent Kaiser(25), Isabella Eckerle(20), Meriem Bekliz(14), Kenneth Adea(14), Caroline Tapparel(10), Catia Alvarez(10), Francisco Rodríguez(8), Samuel Constant(7), Song Huang(6), Olha Puhach(6), Christiane S. Eberhardt(5), Camille Escadafal(5), Benjamin Meyer(4), Christian Drosten(4), Johan Geiser(4), Pascale Sattonnet‐Roche(4), Giulia Torriani(4), Léna Royston(3), Isabelle Piuz(3), Pauline Vetter(3)